Ann: Funding for ATL1103 Phase II Trial and Pipel, page-19

re: Ann: Funding for ATL1103 Phase II Trial a... "ANP has succesfully completed Phase 2, and soon to start Phase 3"

Phase III where ? ? ?

ATL1103 Phase II commencement aimed for 2nd half 2012 with interim results potentially available mid 2013

If your referring to ATL1102 the next step provided term sheets are finalised in the near future is for TJAB to carry out Chronic Toxicology study on the candidate which was always a given first step as TEVA walked from the license agreement in 2010 largely speculated as a result of long term toxicology studies, provided the results from TJAB toxicology are positive they will then move onto a Phase IIb study for MS.